Research Article
BibTex RIS Cite

Miyokardiyal Canlılık Değerlendirmede Nükleer Görüntülemenin Yeri

Year 2015, Volume: 1 Issue: 3, 75 - 78, 18.12.2015

Abstract

Accurate assessment of myocardial viability is very important in patients with CAD and left ventricular dysfunction. Because after the success of revascularization improvement of left ventricular function occurs in a signifi cant proportion of these patients. Cardiac nuclear imaging play important role in assessment of myocardial viability. In particular, PET imaging using 18F-fl uorodeoxyglucose is accepted as the metabolic gold standard of tissue viability. However viability assessment using SPECT techniques are more widely available at lower cost. This review discusses the nuclear medicine imaging tecniques for myocardial viability. 

References

  • Emond M, Mock MB, Davis KB, Fisher LD, et al. Long-term survival of medically
  • treated patients in the coronary artery surgery study(CASS) registry. Circulation
  • ;90:2645-57.)
  • Bonow RO. Identification of viable myocardium. Circulation 1996; 94: 2674–
  • -
  • Tillisch J, Brunken R, Marshall R, Schwaiger M, et al. Reversibility of cardiac wallmotion
  • abnormalities predicted by positron tomography. N Engl J Med 1986;
  • : 884–888.
  • Dilsizian V, Rocco TP, Freedman NM, Leon MB, et al. Enhanced detection
  • of ischemic but viable myocardium by the reinjection of thallium after stressredistribution
  • imaging. N Engl J Med 1990; 323: 141–146.
  • Tamaki N, Kawamoto M, Tadamura E, Magata Y, et al. Prediction of reversible
  • ischemia after revascularization. Perfusion and metabolic studies with positron
  • emission tomography. Circulation 1995; 91: 1697– 1705.
  • Haas F, Haehnel CJ, Picker W, Nekolla S, et al. Preoperative positron emission
  • tomographic viability assessment and perioperative and postoperative risk in
  • patients with advanced ischemic heart disease. J Am Coll Cardiol 1997; 30:
  • –1700.
  • Opie LH. Effects of regional ischemia on metabolism of glucose and fatty acids.
  • Relative rates of aerobic and anaerobic energy production during myocardial
  • infarction and comparison with effects of anoxia. Circ Res 1976; 38: I52– I74.
  • Di Carli MF, Davidson M, Little R, Khanna S, et al. Value of metabolic imaging
  • with positron emission tomography for evaluating prognosis in patients with
  • coronary artery disease and left ventricular dysfunction. Am J Cardiol 1994; 73:
  • –533.
  • Opie LH. Metabolism of the heart in health and disease. II. Am Heart J 1969; 77:
  • –122 contd.
  • Gropler RJ, Geltman EM, Sampathkumaran K, Pérez JE, et al. Comparison of
  • carbon-11-acetate with fluorine-18-fluorodeoxyglucose for delineating viable
  • myocardium by positron emission tomography. J Am Coll Cardiol 1993; 22:
  • –1597.
  • Rubin PJ, Lee DS, Davila-Roman VG, Geltman EM, et al. Superiority of C-11
  • acetate compared with F-18 fluorodeoxyglucose in predicting myocardial
  • functional recovery by positron emission tomography in patients with acute
  • myocardial infarction. Am J Cardiol 1996; 78: 1230–1235.
  • Kitsiou AN, Bacharach SL, Bartlett ML, Srinivasan G, et al. 13N-ammonia
  • myocardial blood flow and uptake: relation to functional outcome of asynergic
  • regions after revascularization. J Am Coll Cardiol 1999; 33: 678–686.
  • Maurea S, Cuocolo A, Soricelli A, Castelli L, et al. Enhanced Detection of Viable
  • Myocardium by Technetium-99m-MIBI Imaging After Nitrate Administration in
  • Chronic Coronary Artery Disease. J. Nucl. Med. 1995, 36, 1945–1952.
  • Batista J.F, Pereztol O, Valdes J.A, Sanchez E, et al. Improved Detection of
  • Myocardial Perfusion Reversibility by Rest-Nitroglycerin Tc-99m-MIBI: Comparison
  • with Tl-201 Reinjection. J. Nucl. Cardiol. 1999, 6, 480–486.
  • Travin MI, Bergmann SR. Assessment of myocardial viability. Semin Nucl Med
  • ; 35:2-16.
  • Stollfuss JC, Haas F, Matsunari I, Neverve J, et al. 99mTc-tetrofosmin SPECT for
  • prediction of functional recovery defined by MRI in patients with severe left
  • ventricular dysfunction: additional value of gated SPECT. J Nucl Med 1999; 40:
  • –1831.
  • Yoshinaga K, Morita K, Yamada S, Komuro K, et al. Low-dose dobutamine
  • electrocardiograph-gated myocardial SPECT for identifying viable myocardium:
  • comparison with dobutamine stress echocardiography and PET. J Nucl Med 2001;
  • : 838–844.
  • Kaynaklar

Miyokardiyal Canlılık Değerlendirmede Nükleer Görüntülemenin Yeri

Year 2015, Volume: 1 Issue: 3, 75 - 78, 18.12.2015

Abstract

Sol ventrikül disfonksiyonu olan koroner arter hastalarında miyokardiyal canlılığın doğru olarak değerlendirilmesi oldukça önemlidir. Çünkü bu hastaların önemli bir kısmında başarılı revaskülarizasyon sonrası sol ventrikül fonksiyonlarında düzelme meydana gelmektedir. Kardiyak nükleer görüntüleme miyokardiyal canlılık değerlendirilmesinde önemli rol oynamaktadır. Özellikle 18F-fl uorodeoxyglucose ile PET görüntüleme doku canlılığı açısından metabolik altın standart olarak kabul ediliyor. Ancak SPECT teknikleri düşük maliyetle daha yaygın olarak kullanılabilir. Bu derlemede miyokardiyal canlılık açısından nükleer tıp yöntemleri tartışılmıştır.

References

  • Emond M, Mock MB, Davis KB, Fisher LD, et al. Long-term survival of medically
  • treated patients in the coronary artery surgery study(CASS) registry. Circulation
  • ;90:2645-57.)
  • Bonow RO. Identification of viable myocardium. Circulation 1996; 94: 2674–
  • -
  • Tillisch J, Brunken R, Marshall R, Schwaiger M, et al. Reversibility of cardiac wallmotion
  • abnormalities predicted by positron tomography. N Engl J Med 1986;
  • : 884–888.
  • Dilsizian V, Rocco TP, Freedman NM, Leon MB, et al. Enhanced detection
  • of ischemic but viable myocardium by the reinjection of thallium after stressredistribution
  • imaging. N Engl J Med 1990; 323: 141–146.
  • Tamaki N, Kawamoto M, Tadamura E, Magata Y, et al. Prediction of reversible
  • ischemia after revascularization. Perfusion and metabolic studies with positron
  • emission tomography. Circulation 1995; 91: 1697– 1705.
  • Haas F, Haehnel CJ, Picker W, Nekolla S, et al. Preoperative positron emission
  • tomographic viability assessment and perioperative and postoperative risk in
  • patients with advanced ischemic heart disease. J Am Coll Cardiol 1997; 30:
  • –1700.
  • Opie LH. Effects of regional ischemia on metabolism of glucose and fatty acids.
  • Relative rates of aerobic and anaerobic energy production during myocardial
  • infarction and comparison with effects of anoxia. Circ Res 1976; 38: I52– I74.
  • Di Carli MF, Davidson M, Little R, Khanna S, et al. Value of metabolic imaging
  • with positron emission tomography for evaluating prognosis in patients with
  • coronary artery disease and left ventricular dysfunction. Am J Cardiol 1994; 73:
  • –533.
  • Opie LH. Metabolism of the heart in health and disease. II. Am Heart J 1969; 77:
  • –122 contd.
  • Gropler RJ, Geltman EM, Sampathkumaran K, Pérez JE, et al. Comparison of
  • carbon-11-acetate with fluorine-18-fluorodeoxyglucose for delineating viable
  • myocardium by positron emission tomography. J Am Coll Cardiol 1993; 22:
  • –1597.
  • Rubin PJ, Lee DS, Davila-Roman VG, Geltman EM, et al. Superiority of C-11
  • acetate compared with F-18 fluorodeoxyglucose in predicting myocardial
  • functional recovery by positron emission tomography in patients with acute
  • myocardial infarction. Am J Cardiol 1996; 78: 1230–1235.
  • Kitsiou AN, Bacharach SL, Bartlett ML, Srinivasan G, et al. 13N-ammonia
  • myocardial blood flow and uptake: relation to functional outcome of asynergic
  • regions after revascularization. J Am Coll Cardiol 1999; 33: 678–686.
  • Maurea S, Cuocolo A, Soricelli A, Castelli L, et al. Enhanced Detection of Viable
  • Myocardium by Technetium-99m-MIBI Imaging After Nitrate Administration in
  • Chronic Coronary Artery Disease. J. Nucl. Med. 1995, 36, 1945–1952.
  • Batista J.F, Pereztol O, Valdes J.A, Sanchez E, et al. Improved Detection of
  • Myocardial Perfusion Reversibility by Rest-Nitroglycerin Tc-99m-MIBI: Comparison
  • with Tl-201 Reinjection. J. Nucl. Cardiol. 1999, 6, 480–486.
  • Travin MI, Bergmann SR. Assessment of myocardial viability. Semin Nucl Med
  • ; 35:2-16.
  • Stollfuss JC, Haas F, Matsunari I, Neverve J, et al. 99mTc-tetrofosmin SPECT for
  • prediction of functional recovery defined by MRI in patients with severe left
  • ventricular dysfunction: additional value of gated SPECT. J Nucl Med 1999; 40:
  • –1831.
  • Yoshinaga K, Morita K, Yamada S, Komuro K, et al. Low-dose dobutamine
  • electrocardiograph-gated myocardial SPECT for identifying viable myocardium:
  • comparison with dobutamine stress echocardiography and PET. J Nucl Med 2001;
  • : 838–844.
  • Kaynaklar
There are 55 citations in total.

Details

Primary Language Turkish
Subjects Health Care Administration
Journal Section Articles
Authors

Muhammet Aşık This is me

Publication Date December 18, 2015
Submission Date December 18, 2015
Published in Issue Year 2015 Volume: 1 Issue: 3

Cite

APA Aşık, M. (2015). Miyokardiyal Canlılık Değerlendirmede Nükleer Görüntülemenin Yeri. Journal of Human Rhythm, 1(3), 75-78.
AMA Aşık M. Miyokardiyal Canlılık Değerlendirmede Nükleer Görüntülemenin Yeri. Journal of Human Rhythm. December 2015;1(3):75-78.
Chicago Aşık, Muhammet. “Miyokardiyal Canlılık Değerlendirmede Nükleer Görüntülemenin Yeri”. Journal of Human Rhythm 1, no. 3 (December 2015): 75-78.
EndNote Aşık M (December 1, 2015) Miyokardiyal Canlılık Değerlendirmede Nükleer Görüntülemenin Yeri. Journal of Human Rhythm 1 3 75–78.
IEEE M. Aşık, “Miyokardiyal Canlılık Değerlendirmede Nükleer Görüntülemenin Yeri”, Journal of Human Rhythm, vol. 1, no. 3, pp. 75–78, 2015.
ISNAD Aşık, Muhammet. “Miyokardiyal Canlılık Değerlendirmede Nükleer Görüntülemenin Yeri”. Journal of Human Rhythm 1/3 (December 2015), 75-78.
JAMA Aşık M. Miyokardiyal Canlılık Değerlendirmede Nükleer Görüntülemenin Yeri. Journal of Human Rhythm. 2015;1:75–78.
MLA Aşık, Muhammet. “Miyokardiyal Canlılık Değerlendirmede Nükleer Görüntülemenin Yeri”. Journal of Human Rhythm, vol. 1, no. 3, 2015, pp. 75-78.
Vancouver Aşık M. Miyokardiyal Canlılık Değerlendirmede Nükleer Görüntülemenin Yeri. Journal of Human Rhythm. 2015;1(3):75-8.